This teaser solution was originally published in late January, but we’re seeing the ad pushed more again now and are getting more questions so I updated this piece to provide some more information and check in on the company. Matt Badiali has been pitching an “Infinite Oil” company in recent weeks in ads for his […]
Articles
Each year I go through all of the stocks that I either own personally or have brought to the attention of the Irregulars (there’s quite a bit of overlap on those lists), and I make sure to update my thoughts and opinion on that stock in an organized and, hopefully, disciplined way — that helps […]
All of you, dear Irregulars, know that Stock Gumshoe is not a “tip sheet,” and I don’t operate a portfolio for other people to emulate or copy, or even attempt to track the stocks we cover as if they were a portfolio of buys and sells with consistent trading advice… but I do keep a […]
Just as I catch up on some of the favorite stocks in the Gumshoe universe at least once each year, so too I need to check in with all of our watchlist companies — but first, a trade to note for you: Among the non-watchlist stocks that I own or have covered recently, I’m tempted […]
I have a few thoughts to share with my favorite Irregulars today for our Friday File (we also shared a new article from Doc Gumshoe earlier today if you’re interested). Today we’re looking at a few trades I’ve made this week (four buys and one sell), updating thoughts on a couple companies I’ve covered before, […]
We’re sharing another “Thoughts from Myron” piece this week as well, so I’ll keep my Friday comments a little briefer than usual. You can catch that latest piece from Myron here, hopefully you’ll find the different perspective he brings to be useful or illuminating in some way. I had Seadrill on the mind earlier this […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
From Biotime's recent press release: BioTime has developed Hextend(R), a blood plasma volume expander for use in surger...
Anyone think now might be a good time to buy?...
It appears that Travis did not uncover evidence that this company has an industry note worthy tech advancement to suppo...
CJ might be a good company, but Argus Research and Ford Equity have sell ratings on the stock....
Thanks for your assessment on CJ Travis. I researched this area for opportunities a while back and found what may be a ...
I'm doubtful of C&J doing anything other than tracking the index, as it has done in the past. If it had showed an ab...
Travis, you nailed this one. C&J will continue to trade in line with WTI. Watch to see if they bring back up any o...